Overview

A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This is a open label, single center, single oral dose, study of PRT054021, in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Portola Pharmaceuticals
Treatments:
Betrixaban